Introduction
============

Congenital hereditary endothelial dystrophy (CHED) is a rare inherited disorder of the corneal endothelium, characterized by corneal opacification and nystagmus. CHED is usually evident at the time of birth or in the early years of life. This disorder is due to the malfunction and degeneration of the corneal endothelium that lead to corneal edema, especially of the stroma, and give the cornea the appearance of ground glass \[[@r1]\]. The condition is known to occur in two genetic forms: autosomal dominant (CHED1, MIM\# [121700](http://omim.org/entry/121700)) and autosomal recessive (CHED2, MIM\# [217700](http://omim.org/entry/217700)), the latter more severe and usually more common. CHED1 and CHED2 have been mapped to chromosome 20 at two distinct loci \[[@r2],[@r3]\]. Vithana et al. \[[@r4]\] identified the CHED2 gene solute carrier family 4, sodium borate transporter, member 11 (*SLC4A11*) through a positional candidate gene approach. SLC4A11, also known as bicarbonate transporter-related protein-1 (BTR1), is a member of the SLC4 family of bicarbonate transporters. In humans, the SLC4A and SLC26 families are the main bicarbonate transporters \[[@r5]\]. The *SLC4A11* gene consists of 18 coding exons and is expressed in several organs and tissues, including the eye, blood, lung, ovary, colon, mouth, embryonic tissue, pancreas, kidney, skin, cranial nerve, ascites, prostate, and brain. The gene encodes an 891-amino-acid-long protein with a calculated molecular mass of 100 kDa, which contains 14 transmembrane domains along with multiple intracellular phosphorylation sites and two extra cellular N-glycosylation sites \[[@r6]\]. Homozygous mutations in *SLC4A11* have also been shown to cause another rare autosomal recessive disorder, corneal dystrophy and perceptive deafness (CDPD, MIM\# [217400](http://omim.org/entry/217400)) or Harboyan syndrome \[[@r7]\]. Interestingly, heterozygous mutations in *SLC4A11* cause Fuchs endothelial corneal dystrophy-4 (FECD4, MIM\# [613268](http://omim.org/entry/613268)) \[[@r8]-[@r10]\].

Mutations in *SLC4A11* have been reported in families with CHED2 from different populations, including India \[[@r4],[@r11]-[@r19]\]. We reported earlier two homozygous mutations in the *SLC4A11* gene in two families with CHED2 ascertained at the Minto Eye Hospital, Bangalore. Here, we report on the mutation analysis of this gene in six additional families with CHED2 identified at the same hospital. We have also reviewed the literature on the contribution of this gene in CHED2, FECD4, and CDPD.

Methods
=======

Familie**s**
------------

We recruited seven patients from six consanguineous families ([Figure 1](#f1){ref-type="fig"}), three boys and four girls, aged 3-6 years, at the Minto Eye Hospital, Bangalore, Karnataka. Consanguinity was due to maternal uncle and niece marriage in all the families. All family members were examined in detail by D. Ravi Prakash and S. Yathish. Their state of health at the time of recruitment was good with the exception that all affected individuals from six families had congenital bilateral cloudy cornea ([Figure 2](#f2){ref-type="fig"}). None of the parents had cloudy cornea or any other systemic involvement.

![Deoxyribonucleic acid sequence analysis of individuals. Sequencing chromatograms of the heterozygous parents and affected homozygous individuals from family 3, 4, 5, 6, 7, and 8 are shown. Arrows mark the nucleotide change in a heterozygous state in parents and in a homozygous state in affected individuals. + and m denote the wild type and the mutant alleles.](mv-v19-1694-f1){#f1}

![Clinical features of affected individual II-1 from family 7. **A**: Cornea showing opacification. **B**: Slit-lamp examination of the cornea showing thickening and opacification.](mv-v19-1694-f2){#f2}

Genetic analysis
----------------

For genetic analysis, 3--5 ml of peripheral blood sample was drawn from each individual in a Vacutainer EDTA tube (Becton Dickinson, Franklin Lakes, NJ) and used for genomic DNA isolation using a Wizard genomic DNA extraction kit (Promega, Madison, WI). This research followed the tenets of the Declaration of Helsinki and the guidelines of the Indian Council of Medical Research, New Delhi. To determine if CHED2 in these families is due to mutations in the *SLC4A11* gene, the entire coding region of the *SLC4A11* gene was amplified using primers that amplify all coding exons and their intron-exon junctions \[[@r12]\]. Mutations were identified by sequencing the PCR products from one affected individual from each family on an ABIprism A310-automated sequencer (Life Technologies, Carlsbad, CA). PCR was performed in a total volume of 25 µl containing 50 ng of genomic DNA, 1.5 mM MgCl~2~, 200 µM of each deoxynucleotide triphosphate, 1X buffer, and 1 unit of *Taq* DNA polymerase (Sigma-Aldrich, Bangalore, India) using a PTC-100 thermocycler (MJ Research, Waltham, MA). Before sequencing, the PCR products were purified using a GenElute gel extraction kit (Sigma-Aldrich, St. Louis, MO). Once a mutation was identified, all members of the family were sequenced to identify the mutation. Allele-specific PCR was performed to determine if a specific mutation was present in 50 ethnically matched normal controls ([Table 1](#t1){ref-type="table"}).

###### Primers used for mutation analysis in normal controls by allele-specific PCR.

  **Mutation**   **Primer sequence (5′-3′)**                                    **Tm (°C)**   **Amplicon size (bp)**
  -------------- -------------------------------------------------------------- ------------- ------------------------
  c.1831T\>C     F:GCGTGCGAGAGATCCTGTCCGACC 14R\*: AGTAGGGGACAGGCTACTGCTATGCC   70            168
  c.1249G\>A     F:GACCATAGCCGGGCAGAGCATCA 11R\*:GGGCTGAACCAGATCCCAAGCCTTGA     66            379
  c.2170C\>G     F:CTTGGATCCATGCCGCCTACCCCGA 16R\*:GGCCAGAGGCTCCCCACTCCTCAG     61            149
  c.785C\>T      8F\*:CCCGGGCAGGGCCTCCTCTGTTTC R:GCGCGCCACCTCCATCGCAGTCTTAA     72            86

Abbreviations: F, forward primer; R, reverse primer, Tm, annealing temperature; and, bp, base pairs. \*Primers are described in Kumar et al. \[[@r12]\].

To find the functional significance of the mutated amino acid residues, SLC4A11 protein sequences from different species were aligned by the [ClustalW2](http://www.ebi.ac.uk/Tools/msa/clustalw2/) program. To predict the effect of mutations on SLC4A11 function, we used two bioinformatics programs: [PolyPhen-2](http://genetics.bwh.harvard.edu/pph2/) and [MutationTaster](http://www.mutationtaster.org). The output score from the PolyPhen-2 program ranges from 0 to a positive number, where 0 is neutral, and a high positive number is damaging to protein function. The output from the MutationTaster program is a p (probability) value. A p value close to 1 indicates the high "security" of the prediction that the mutation is damaging to protein function.

Results and Discussion
======================

DNA sequence analysis of the *SLC4A11* gene showed four novel mutations, c.1831T\>C (p.Cys611Arg), c.1249G\>A (p.Gly417Arg), c.2170C\>G (p.His724Asp), and c.785C\>T (p.Thr262Ile) in families 3, 4, 5, and 6, respectively, and a known mutation, c.2606G\>A (p.Arg869His), in family 8 in a homozygous state ([Figure 1](#f1){ref-type="fig"}; [Table 2](#t2){ref-type="table"}). Interestingly, the c.1249G\>A (p.Gly417Arg) mutation was also observed in family 7 ([Figure 1](#f1){ref-type="fig"}).

###### Effect of novel mutations on SLC4A11 function by the *in silico* analysis.

  Sl.\#   Family         Mutation        PolyPhen-2 score         Mutation Taster score
  ------- -------------- --------------- ------------------------ -----------------------
  1       Family 3       c.1831T\>C      Probably damaging with   Disease causing with
                         (p.Cys611Arg)   a score of 0.99          a p value of 0.99
  2       Family 4 and   c.1249 G\>A     Probably damaging with   Disease causing with
          Family 7       (p.Gly417Arg)   a score of 1             a p value of 0.99
  3       Family 5       c.2170 C\>G     Probably damaging with   Disease causing with
                         (p.His724Asp)   a score of 1             a p value of 0.99
  4       Family 6       c.785C\>T       Probably damaging        Disease causing with
                         (p.Thr262Ile)   with a score of 1        a p value of 0.99

Based on the following criteria, we considered the four novel changes mutations. 1) The changes were segregating in the family ([Figure 1](#f1){ref-type="fig"}). 2) The changed amino acids were highly conserved across species ([Figure 3](#f3){ref-type="fig"}). 3) The changes were not observed in 50 normal controls (data not shown). 4) The PolyPhen-2 program predicted all four changes would probably be damaging ([Table 2](#t2){ref-type="table"}). 5) The MutationTaster program predicted the four changes would be disease causing ([Table 2](#t2){ref-type="table"}).

![Conservation of the amino acid residues across different species. Arrows mark the conservation of mutated amino acid residues Cys611, Gly417, His724, and Thr262 across different species in SLC4A11. The number refers to the position of the amino acid residue.](mv-v19-1694-f3){#f3}

We performed a literature review to catalog all the mutations described to date in the *SLC4A11* gene. With the four novel mutations described in the present study, the total number of mutations in this gene reaches 78 ([Table 3](#t3){ref-type="table"}). These include 42 missense, nine nonsense, four splice site, and 23 insertion-deletion mutations ([Table 3](#t3){ref-type="table"}). The mutations are scattered across the gene ([Table 3](#t3){ref-type="table"}), suggesting that its entire coding region needs to be sequenced in an affected individual to identify the mutation.

###### Known mutations in the *SLC4A11* gene.

  **Sl.** **no.**   **Mutation**                                      **Exon/ intron (IVS)**   **Nature of mutation**   **State of zygosity**                                                                    **Effect on protein**                                                          **Phenotype**    **Number and ethnic origin of family**              **Reference**
  ----------------- ------------------------------------------------- ------------------------ ------------------------ ---------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ ---------------- --------------------------------------------------- --------------------------------
  1                 c.99_100delTC (p.S33SfsX18)                       2                        Deletion                 Heterozygous                                                                             Truncation of protein and addition of novel amino acids                        FECD4            1 Chinese                                           \[[@r8]\]
  2                 c.140delA(p.Y47SfsX69)                            2                        Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            1 Indian                                            \[[@r11]\]
  3                 c.246_247delTTinsA (p.R82RfsX33)                  2                        Indel                    Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            1 Indian                                            \[[@r14]\]
  4                 c.306delC (p.G103VfsX13)                          3                        Deletion                 Compound heterozygous with an unknown second mutation                                    Truncation of protein and addition of novel amino acids                        CHED2            1 Indian                                            \[[@r11]\]
  5                 c.334C\>T (p.R112X)                               3                        Nonsense                 Homozygous and compound heterozygous with c.2318C\>T (p.773L) and c.1751C\>A (p.T773K)   Truncation of protein                                                          CHED2            3 Indian                                            \[[@r11]\]
  6                 c.353_356delAGAA (p.K118TfsX11)                   4                        Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            2 Indian                                            \[[@r4]\]
  7                 c.374G\>A (p.R125H)                               4                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Indian                                            \[[@r16]\]
  8                 c.427G\>A (p.E143K)                               4                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Indian                                            \[[@r13]\]
  9                 c.520delGCTTCGCC (p.R158fs)                       4                        Out-of-frame deletion    Homozygous                                                                               Truncation of protein                                                          CHED2            1 Saudi Arabian                                     \[[@r18]\]
  10                c.473_481delGCTTCGCCAinsC (p.R158PfsX3)           4                        Indel                    Homozygous                                                                               Truncation of protein and addition of novel amino acids, absence of all TMD    CHED2            1 Indian                                            \[[@r16]\]
  11                c.473_480del8 bp (p.R158QfsX4)                    4                        Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2 and CDPD   2 Indian, 1 Gipsy (Eastern European)                \[[@r7],[@r11]\]
  12                c.478G\> A (p.A160T)                              4                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            2 Indian                                            \[[@r14],[@r16]\]
  13                c.501G\>C (p.E167D)                               4                        Missense                 Heterozygous                                                                             Reduction in the mature 120 kDa form, with addition of 100 kDa species         FECD4            Northern European (No. of families not mentioned)   \[[@r10]\]
  14                c.618_619delAG (p.V208AfsX38)                     5                        Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            2 Indian                                            \[[@r11]\]
  15                c.625C\>T (p.R209W)                               5                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            2 Indian                                            \[[@r11]\]
  16                c.637T\>C (p.S213P)                               5                        Missense                 Compound heterozygous with c.2566A\>G (p.M856V)                                          May have an effect on N-terminal cytoplasmic domain                            CDPD             1 Sephardi Jewish                                   \[[@r7]\]
  17                c.638C\>T (p.S213L)                               5                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Indian                                            \[[@r11]\]
  18                c.654 (−97)\_c.778 (−1488)del698 (p.C218KfsX49)   5--6                     Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids, absence of all TMDs   CHED2            1 Indian                                            \[[@r16]\]
  19                c.743G\>A (p.S232N)                               6                        Missense                 Compound heterozygous with c.1033A\>T (p.Arg329X)                                        Loss of function or membrane localization                                      CHED2            1 US family of Chinese ancestry                     \[[@r15]\]
  20                c.697C\>T (p.R233C)                               6                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Indian                                            \[[@r11]\]
  21                c.720G\>A (p.W240X)                               6                        Nonsense                 Homozygous                                                                               Truncation of protein                                                          CHED2            1 British                                           \[[@r13]\]
  22                c.785C\>T (p.T262I)                               6                        Missense                 Homozygous                                                                               Damaging to protein function                                                   CHED 2           1 Indian                                            Present study
  23                c.806C\>T (p.A269V)                               7                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            2 Indian                                            \[[@r16]\]
  24                c.812C\>T (p.T271M)                               7                        Missense                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Saudi Arabian                                     \[[@r17]\]
  25                c.845G\>C (p.R282P)                               7                        Missense                 Heterozygous                                                                             Immature protein                                                               FECD4            Northern European (No. of families not mentioned)   \[[@r10]\]
  26                c.859_862delGAGA insCCT (p.E287PfsX21)            7                        Indel                    Homozygous                                                                               Truncation of protein and addition of novel amino acids, absence of all TMDs   CHED2            1 Indian                                            \[[@r12]\]
  27                c.878_889del12 p.E293_E296del                     7                        Deletion                 Homozygous                                                                               May have an effect on N-terminal cytoplasmic domain                            CHED2            1 Indian                                            \[[@r11]\]
  28                c.1033A\>T (p.R329X)                              7                        Nonsense                 Compound heterozygous with c.743G\>A (p.Ser232Asn)                                       Premature truncation of the transcript                                         CHED2            1 US family of Chinese ancestry                     \[[@r15]\]
  29                c.996+26C\_+44Cdel19                              IVS-7                    Deletion                 Homozygous                                                                               Not Known                                                                      CHED2            2 Indian                                            \[[@r11]\]
  30                c.1044+25del19nt                                  IVS-7                    Deletion                 Homozygous                                                                               Not known                                                                      CHED2            1 Saudi Arabian                                     \[[@r18]\]
  31                c.1091--1G\>C                                     IVS-8                    Splice site              Homozygous                                                                               Not known                                                                      CHED2            1 Indian                                            \[[@r11]\]
  32                c.1156T\>C (p.C386R)                              9                        Missense                 Homozygous                                                                               Disruption of TMD 1                                                            CHED2            4 Indian                                            \[[@r13],[@r16],[@r19]\]
  33                c.1228G\>C (p.G394R)                              9                        Missense                 Homozygous                                                                               Disruption of TMD1                                                             CHED2            1 Saudi Arabian                                     \[[@r18]\]
  34                c.1195G\>A (p.E399K)                              9                        Missense                 Heterozygous                                                                             Aberrant glycosylation and cellular localization                               FECD4            1 Indian                                            \[[@r8]\]
  35                c.1202C\>A (p.T401L)                              9                        Missense                 Compound heterozygous with c.1418T\>G (p.L473R)                                          Not known                                                                      CHED2            1 Indian                                            \[[@r11]\]
  36                c.1249 G\>A (p.G417R)                             10                       Missense                 Homozygous                                                                               Damaging to protein function                                                   CHED2            2 Indian                                            Present study
  37                c.1253G\>A (p.G418D)                              10                       Missense                 Homozygous                                                                               Disruption of TMD 2                                                            CHED2            1 Indian, 1 Saudi Arabian                           \[[@r11],[@r18]\]
  38                c.1317_1322del6ins8 (p.L440VfsX6)                 10                       Indel                    Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            1 Indian                                            \[[@r11]\]
  39                c.1378_1381delTACGinsA (p.Y460_A461 delinsT)      11                       Indel                    Homozygous                                                                               Not known                                                                      CDPD             1 Dominican Republican                              \[[@r7]\]
  40                c.1391G\>A (p.G464D)                              11                       Missense                 Homozygous                                                                               Conformation change                                                            CHED2            3 Pakistani                                         \[[@r4]\]
  41                c.1463G\>A (p.R488K)                              11                       Missense                 Homozygous                                                                               Not known                                                                      CDPD             1 Moroccan                                          \[[@r7]\]
  42                c.1466C\>T (p.S489L)                              12                       Missense                 Homozygous                                                                               Conformation change                                                            CHED2            1 Pakistani, 1 Indian                               \[[@r4],[@r11]\]
  43                c.1577A\>G (p.Y526C)                              12                       Missense                 Heterozygous                                                                             Partial loss of localization at the membrane                                   FECD4            Northern European (No. of families not mentioned)   \[[@r10]\]
  44                c.1704_1705delCT (p.H568HfsX177)                  13                       Deletion                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            1 Indian                                            \[[@r14]\]
  45                c.1723G\>A (p.V575M)                              13                       Missense                 Heterozygous                                                                             Partial loss of localization at the membrane                                   FECD4            Northern European (No. of families not mentioned)   \[[@r10]\]
  46                c.1748G\>A (p.G583D)                              13                       Missense                 Heterozygous                                                                             Immature protein                                                               FECD4            Northern European (No. of families not mentioned)   \[[@r10]\]
  47                c.1751C\>A (p.T584K)                              13                       Missense                 Homozygous and compound heterozygous with c.334C\>T (p.Arg112X)                          Disruption of TMD 6                                                            CHED2            2 Indian                                            \[[@r11]\]
  48                c.1813C\>T (p.R605X)                              14                       Nonsense                 Homozygous and compound heterozygous with an unknown second mutation                     Truncation of protein                                                          CHED2            6 Indian                                            \[[@r4],[@r11],[@r14]\]
  49                c.1831T\>C (p.C611R)                              14                       Missense                 Homozygous                                                                               Damaging to protein function                                                   CHED2            1 Indian                                            Present study
  50                c.1894G\>T (p.E632X)                              14                       Nonsense                 Homozygous                                                                               Truncation of protein                                                          CHED2            2 Indian                                            \[[@r11],[@r14]\]
  51                IVS15 −6 \_ −16 delins GGCCGGCCGG                 IVS-15                   Indel                    Homozygous                                                                               Inactivation of splice acceptor site                                           CHED2            1 Indian                                            \[[@r4]\]
  52                c.2014_2016delTTC (p.F672del)                     15                       In-frame deletion        Homozygous                                                                               Disruption of TMD8                                                             CHED2            1 Indian                                            \[[@r12]\]
  53                c.2067--6\_-16delinsGGCCGGCCGG                    IVS-15                   Splice site              Homozygous                                                                               Inactivation of an acceptor splice site                                        CHED2            1 Indian                                            Cited in \[[@r16]\]
  54                c.2114+1G\>A                                      IVS-15                   Donor Splice site        Homozygous                                                                               Inclusion of intron 15                                                         CHED2            1 Saudi Arabian                                     \[[@r18]\]
  55                c.2126G\>A (p.G709E)                              15                       Missense                 Heterozygous                                                                             Aberrant glycosylation and cellular localization                               FECD             1 Chinese                                           \[[@r8]\]
  56                c.2170 C\>G (p.His724Asp)                         15                       Missense                 Homozygous                                                                               Damaging to protein structure                                                  CHED2            1 Indian                                            Present study
  57                c.2224G\>A (p.G742R)                              16                       Missense                 Heterozygous                                                                             Reduction in the mature 120-kDa form, with addition of 100-kDa species         FECD             Northern European (No. of families not mentioned)   \[[@r10]\]
  58                c.2233_2240dup TATGACAC (p.T747TfsX6)             16                       Duplication              Compound heterozygous with c.2528T\>C (p.L843P)                                          Aberrantly truncated protein of 916 residues                                   CDPD             1 South American Indian                             \[[@r7]\]
  59                c.2236C\>T (p.R757X)                              16                       Nonsense                 Homozygous                                                                               Protein truncation                                                             CHED2            2 Saudi Arabian                                     \[[@r18]\]
  60                c.2240 +1G\>A                                     IVS-16                   Splice site              Homozygous and compound heterozygous with an unknown second mutation                     Inactivation of splice donor site                                              CHED2            1 British, 1 Indian                                 \[[@r13],[@r19]\]
  61                c.2261C\>T (p.T754M)                              17                       Missense                 Heterozygous                                                                             Aberrant glycosylation and cellular localization                               FECD4            1 Chinese                                           \[[@r8]\]
  62                c.2263C\>T (p.R755W)                              17                       Missense                 Homozygous                                                                               Disruption of TMD 11                                                           CHED2            3 Indian                                            \[[@r11],[@r13],[@r16]\]
  63                c.2264G\>A (p.R755Q)                              17                       Missense                 Homozygous and compound heterozygous with c.2623C\>T (p.Arg875X)                         Conformation change                                                            CHED2            4 Indian, 1 Myanmar                                 \[[@r4],[@r11],[@r13],[@r14]\]
  64                c.2318C\>T (p.P773L)                              17                       Missense                 Homozygous and compound heterozygous with c.334C\>T (p.R112X)                            Disruption of TMD 11                                                           CHED2            3 Indian                                            \[[@r11],[@r16]\]
  65                c.2389_2391delGAT (p.D797del)                     17                       Deletion                 Homozygous                                                                               Disruption of TMD 12                                                           CHED2            1 Indian                                            \[[@r11]\]
  66                c.2398C\>T (p.Q800X)                              17                       Nonsense                 Compound heterozygous with c.2437--1G\>A                                                 Truncation of protein                                                          CHED2            1 British                                           \[[@r13]\]
  67                c.2407C\>T (p.Gln803X)                            17                       Nonsense                 Homozygous                                                                               Truncation of protein                                                          CHED2            1 Indian                                            \[[@r11]\]
  68                c.2411G\>A (p.R804H)                              18                       Missense                 Homozygous                                                                               Conformation change                                                            CHED2            1 Indian family                                     \[[@r14]\]
  69                c.2420delTinsGG (p.L807RfsX71)                    18                       Missense                 Homozygous                                                                               Truncation of protein and addition of novel amino acids                        CHED2            1 Indian family                                     \[[@r14]\]
  70                c.2423_2454del 32nt (p.Leu808ArgfsX110)           17                       Deletion                 Compound heterozygous with c.2528T\>C (p.Leu843Pro)                                      Aberrantly truncated protein of 916 residues                                   CDPD             1 Dutch                                             \[[@r7]\]
  71                c.2470G\>A (p.V824M)                              18                       Missense                 Homozygous                                                                               Not known                                                                      CHED2            6 Indian                                            \[[@r7],[@r11],[@r19]\]
  72                c.2498C\>T (p.T833M)                              18                       Missense                 Homozygous                                                                               Conformation change                                                            CHED2            2 Indian                                            \[[@r14]\]
  73                c.2500G\>A (p.G834S)                              18                       Missense                 Heterozygous                                                                             Immature protein                                                               FECD             Northern European (No. of families not mentioned)   \[[@r10]\]
  74                c.2506 C\>T (p.Q836X)                             18                       Nonsense                 Compound heterozygous with c.2318C\>T (p.P773L)                                          Truncation of protein                                                          CHED2            1 Indian                                            \[[@r16]\]
  75                c.2518--2520 delCTG (p.L840del)                   18                       In-frame deletion        Homozygous                                                                               Disrupts the appropriate assembly or localization of protein in the membrane   CHED2            1 Indian                                            \[[@r19]\]
  76                c.2605C\>T (p.R869C)                              18                       Missense                 Homozygous                                                                               Conformation change                                                            CHED2            3 Indian, 1 Middle Eastern                          \[[@r4],[@r11],[@r13]\]
  77                c.2606G\>A (p.R869H)                              18                       Missense                 Homozygous                                                                               Damaging to protein structure                                                  CHED2            3 Indian                                            \[[@r14]\], Present study
  78                c.2618T\>C (p.L873P)                              19                       Missense                 Homozygous                                                                               Disruption of TMD 14                                                           CHED2            1 Indian                                            \[[@r16]\]

CDPD is a degenerative corneal disorder characterized by the association of congenital hereditary endothelial dystrophy with progressive sensorineural hearing loss. The ocular manifestations in CDPD include diffuse bilateral corneal edema occurring with severe corneal clouding, blurred vision, visual loss, and nystagmus, which are usually present at birth or within the neonatal period and are indistinguishable from CHED2. The sensorineural hearing loss is slowly progressive and can be identified only during the second decade of life \[[@r20]\]. As stated, homozygous mutations in *SLC4A11* cause not only CHED2 but also CDPD. One of the mutations, c.473_480del8bp (p.R158QfsX4), causes CHED2 and CDPD ([Table 3](#t3){ref-type="table"}).

Why some individuals also develop perceptive deafness along with corneal dystrophy due to mutations in *SLC4A11* is unclear. However, it could be due to an additional environmental effect and/or genetic modifiers. Morris et al. \[[@r21]\] showed differential expression of *SLC4A11* in the inner ear of mice specifically in the region of the stria vascularis. Taking this fact into account, Desir et al. \[[@r7]\] postulated that corneal dystrophy and perceptive deafness might have a common origin in the neural crest cells from which the stria vascularis and the corneal endothelium develop. Further, four mutations (p.S213P, p.Y460_A461 delinsT, p.R488K, and p.Leu808ArgfsX110) are specific to only CDPD ([Table 3](#t3){ref-type="table"}), and none of the 11 heterozygous mutations causing FECD (FECD4) are found in patients with CHED2 and CDPD ([Table 3](#t3){ref-type="table"}). FECD is a progressive degeneration of the corneal endothelium leading to thickened Descemet's membrane, a collagen-rich basal lamina secreted by the endothelium, and reduced vision. In patients with FECD, corneal endothelial cells die, as a result of which bumps called guttae form on the back of the cornea. This causes the cornea to swell and distort vision, resulting in pain and severe visual impairment \[[@r8],[@r22]\].

Why some heterozygous mutations in *SLC4A11* cause FECD4 is also not clear. However, it could be speculated on. The involvement of *SLC4A11* in various corneal dystrophies suggests a significant genetic overlap occurs across several corneal dystrophies and they might share a common pathomechanism \[[@r10]\]. Moreover, the characteristic abnormal posterior non-banded zone of the Descemet's membrane, which represents an abnormal function of the corneal endothelium in CHED2 and FECD4, underlies the importance of the SLC4A11 protein for the proper development and differentiation of the corneal endothelium and may explain how the same gene can be involved in the pathogenesis of CHED2 and FECD4 \[[@r8],[@r22]\]. In addition, a combination of mechanisms may be at play, with partial loss of function and gradual accumulation of the aberrant misfolded protein having a role in FECD4 pathology \[[@r8]\].

It is not surprising to find mutations in *SLC4A11* causing three different disorders. Similar to *SLC4A11*, mutations in the same gene are known to cause different disorders. For example, null mutations in *CEP290* (*NPHP6*) cause Meckel syndrome (MKS4, MIM\# [611134](http://omim.org/entry/611134)) \[[@r23]\], Bardet-Biedl syndrome (BBS14, MIM\# [209900](http://omim.org/entry/209900)) \[[@r24]\], and Joubert syndrome (JBTS5, MIM\# [610188](http://omim.org/entry/610188)) \[[@r25],[@r26]\], while hypomorphic mutations in the same gene lead to Leber congenital amaurosis (LCA10, MIM\# [611755](http://omim.org/entry/611755)) \[[@r27]\].

In summary, we have identified four novel mutations in the *SLC4A11* gene in the present study. With the four novel mutations reported here, the total number of mutations described to date in *SLC4A11* reaches 78. Further, this information will be useful for providing rapid prenatal diagnosis and genetic counseling to families and their relatives.
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